Results 161 to 170 of about 281,748 (215)

Large intramuscular hematoma due to acquired Factor VIII inhibitors in post Polycythemia Vera-Myelofibrosis. [PDF]

Clin Hematol Int
Prabhu RS, V S SR, S N R.
europepmc   +1 more source

Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design. [PDF]

Ann Hematol
De Stefano V, Passamonti F, Palandri F, Ramundo F, Rossi E, Betti S, Fagiolo L, Guglielmelli P, Abagnale DP, Pugliese N, Cattaneo D, Iurlo A, Branzanti F, Dedola A, Catellani H, Tieghi A, Basso M, Calistri E, Elli EM, Masselli E, Morsia E, Benevolo G, Breccia M, de Fazio V, Di Perna M, Marchetti M, Santoro M, Tafuri A, Castiglioni C, Rotella C, Siragusa S, Vannucchi AM, PROSPERO Study group.   +32 more
europepmc   +1 more source

Intersecting Pathologies: Polycythemia Vera and Recurrent Infections in an Elderly Patient. [PDF]

Cureus
Saha P, Sahin E, Nadella N, Siddiqui AM, Edara L.   +4 more
europepmc   +1 more source

Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfa. [PDF]

Blood Adv
Kalmer M, Grasshoff M, Maié T, Pannen K, Toledo MAS, Vieri M, Olschok K, Lemanzyk R, Lazarevic J, Junge B, Baumeister J, Galauner A, Chapal Ilani N, Bar D, Colin E, Cheng M, Schifflers J, Kricheldorf K, Schemionek M, Brümmendorf TH, Weiskirchen R, Shlush L, Zenke M, Chatain N, Costa IG, Koschmieder S.   +25 more
europepmc   +1 more source

[Recent advances in polycythemia vera treatment].

, 2020
Yoko Edahiro
openalex   +2 more sources

Masked polycythemia Vera (mPV): Results of an international study

American journal of hematology/oncology, 2018

semanticscholar   +1 more source

Neutrophil-to-Lymphocyte ratio as surrogate for JAK2^V617F suppression and event-free survival in polycythemia vera. [PDF]

Blood Cancer J
Barbui T, Ghirardi A, Empson V, Fenili F, Loscocco GG, Condorelli A, Iurlo A, Cattaneo D, Rossi E, De Stefano V, Guglielmelli P, Klade C, Gisslinger H, Rambaldi A, Scandura JM, Vannucchi AM.   +15 more
europepmc   +1 more source

Author response for "Acute myeloid leukemia arising from polycythemia vera underwent reversion to chronic phase of myeloproliferative neoplasm status post chemotherapy: biclonal myeloid neoplasms with genomic evidence of a common early hematopoietic progenitor"

, 2020
Yue Zhao, Gina Sotolongo, Kristen Deak, Endi Wang   +3 more
openalex   +1 more source

Polycythemia vera and essential thrombocythemia in children, still a challenge for pediatricians. [PDF]

Eur J Pediatr
Picard A, Bayart S, Deparis M, De Maricourt CD, Haro S, Jourdain A, Mallebranche C, Rialland F, Luque Paz D, Pastoret C, Gandemer V, Cousin E.   +11 more
europepmc   +1 more source

Correction: Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera. [PDF]

Int J Hematol
Kirito K, Sugimoto Y, Gotoh A, Takenaka K, Ichii M, Inano T, Shirane S, Ito M, Zagrijtschuk O, Qin A, Kawase H, Sato T, Komatsu N, Shimoda K.   +13 more
europepmc   +1 more source